Comparison of the Efficacy and Economy of Sequential Therapy and Triple Therapy of Esomeprazole Combined with Clarithromycin and Amoxicillin for Hp Positive Duodenal Ulcer
Jian-ye WU,Ying-qun ZHOU,Chuan-yong GUO
DOI: https://doi.org/10.19803/j.1672-8629.2016.10.002
2016-01-01
Abstract:objective To analyze and compare the efifcacy and economy of sequential therapy and triple therapy of esomeprazole combined with clarithromycin and amoxicillin for Helicobacterpylori (Hp) positive duodenal ulcer, and provide the reference for eradication of Hp. Methods 290 patients with Hp positive duodenal ulcer from January 2015 to June 2016 in our hospital were studied prospectively. All of the patients were divided into three groups according to the visiting sequence, including 97 cases who received the modiifed sequential therapy as the modiifed sequential group, 97 cases who received the traditional sequential therapy as the traditional sequential group, and 96 cases who received the standard triple therapy as the standard triple group. Patients in the modiifed sequential group were provided 20 mg of esomeprazole, 500 mg of clarithromycin twice daily for the ifrst 5 days, followed by 20 mg of esomeprazole, 500 mg of clarithromycin, and 1 000 mg of amoxicillintwice daily for the remaining 5 days. Patients in the traditional sequential group were given 20 mg of esomeprazole, 1 000 mg of amoxicillin twice daily for the ifrst 5 days, followed by 20 mg of esomeprazole, 500 mg of clarithromycin, and 1 000 mg of amoxicillin twice daily for the remaining 5 days. Patients in the standard triple group received 20 mg of esomeprazole, 500 mg of clarithromycin, and 1 000 mg of amoxicillin twice daily for standard 10-day therapy. All of the drugs were administered 2 times a day, the course of treatment was 10 days. The Hp eradication rate and adverse reaction of 3 groups were observed, the efifcacy and cost analysis of the 3 groups were evaluated. Results A total of 275 patients were followed-up at the end of study, the Hp eradication rates of the modified sequential group, the traditional sequential group and the standard triple group were 88.66%(ITT) and 92.47%(PP), 84.54%(ITT) and 89.13%(PP), 72.92%(ITT) and 77.78%(PP).The Hp eradication rates of the modiifed sequential group and traditional sequential group were significantly higher than those of the standard triple group (P< 0.05). 247 cases of Hp were isolated and cultured successfully, resistant rate of clarithromycin was 13.36% (33/247), no amoxicillin resistant strains. The eradication rates of clarithromycin resistant Hp in the modiifed sequential group, traditional sequential group and standard triple group were 81.82%(9/11), 80.00%(8/10) and 33.33%(4/12) respectively, and the eradication rate in the modiifed sequential group and traditional sequential group were signiifcantly higher than that in the standard triple group (P<0.05). The eradication rates of sensitive strains in three groups were 93.90% (77/82), 90.24% (74/82) and 84.62% (66/78) respectively, without signiifcant difference among the three groups (P>0.05). There was no signiifcant difference in the total effective rate and incidence of adverse reactions among the three groups (P>0.05). The cost-effectiveness ratio and incremental cost-effectiveness ratio of the modiifed sequential group and traditional sequential group were slightly better than those of the standard triple group. Conclusion The sequential therapy and triple therapy of esomeprazole combined with clarithromycin and amoxicillin can be effective for Hp positive duodenal ulcer. However, the sequential therapy has higher Hp eradication rate and economic value than the standard triple therapy. The modiifed improved penetration therapy did not show any advantages in this study and still need to be further explored.